Robeco Institutional Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$208M Sell
2,008,760
-340,684
-15% -$30.4M 0.26% 93
2026
Q1
$169M Sell
2,349,444
-989,300
-30% -$76.2M 0.24% 114
2025
Q4
$265M Buy
3,338,744
+243,501
+8% +$19.2M 0.38% 55
2025
Q3
$233M Buy
3,095,243
+432,132
+16% +$29.6M 0.34% 72
2025
Q2
$184M Buy
2,663,111
+2,372,121
+815% +$156M 0.3% 79
2025
Q1
$19.7M Buy
290,990
+73,583
+34% +$4.4M 0.04% 334
2024
Q4
$9.76M Sell
217,407
-252,890
-54% -$14.2M 0.02% 450
2024
Q3
$29.6M Sell
470,297
-16,681
-3% -$973K 0.06% 275
2024
Q2
$28.8M Buy
486,978
+77,266
+19% +$4.83M 0.06% 266
2024
Q1
$32.7M Sell
409,712
-169,132
-29% -$12.9M 0.07% 261
2023
Q4
$45.7M Sell
578,844
-31,472
-5% -$2.24M 0.11% 196
2023
Q3
$42.6M Sell
610,316
-68,712
-10% -$4.87M 0.11% 196
2023
Q2
$46.9M Sell
679,028
-824,472
-55% -$58.7M 0.12% 184
2023
Q1
$112M Sell
1,503,500
-201,237
-12% -$16.9M 0.3% 90
2022
Q4
$159M Sell
1,704,737
-92,902
-5% -$8.96M 0.46% 58
2022
Q3
$171M Buy
1,797,639
+3,387
+0.2% +$335K 0.55% 43
2022
Q2
$166M Buy
1,794,252
+201,671
+13% +$19.7M 0.52% 47
2022
Q1
$161M Buy
1,592,581
+79,332
+5% +$8.33M 0.38% 64
2021
Q4
$156M Sell
1,513,249
-60,029
-4% -$5.55M 0.33% 78
2021
Q3
$134M Buy
1,573,278
+41,849
+3% +$3.51M 0.3% 91
2021
Q2
$128M Buy
1,531,429
+173,543
+13% +$14.2M 0.28% 96
2021
Q1
$102M Buy
1,357,886
+8,514
+0.6% +$620K 0.25% 103
2020
Q4
$92.2M Buy
1,349,372
+17,606
+1% +$1.15M 0.24% 100
2020
Q3
$77.8M Buy
1,331,766
+314,890
+31% +$19.6M 0.24% 109
2020
Q2
$66.1M Buy
1,016,876
+411,595
+68% +$25.9M 0.22% 113
2020
Q1
$35.9M Buy
605,281
+55,272
+10% +$3.69M 0.14% 188
2019
Q4
$40.9M Buy
550,009
+15,845
+3% +$1.11M 0.13% 215
2019
Q3
$33.7M Buy
534,164
+15,957
+3% +$946K 0.12% 225
2019
Q2
$28.2M Sell
518,207
-20,101
-4% -$1.08M 0.1% 266
2019
Q1
$29M Sell
538,308
-109,633
-17% -$6.77M 0.11% 262
2018
Q4
$42.4M Buy
647,941
+119,752
+23% +$8.94M 0.19% 151
2018
Q3
$41.6M Sell
528,189
-21,404
-4% -$1.53M 0.16% 171
2018
Q2
$35.4M Sell
549,593
-135,660
-20% -$8.94M 0.16% 169
2018
Q1
$42.6M Buy
685,253
+757
+0.1% +$54.3K 0.2% 136
2017
Q4
$49.6M Buy
684,496
+294,246
+75% +$21.4M 0.26% 110
2017
Q3
$31.7M Buy
390,250
+114,908
+42% +$9.09M 0.2% 142
2017
Q2
$22.2M Sell
275,342
-214,600
-44% -$16.9M 0.14% 183
2017
Q1
$38.5M Buy
489,942
+114,349
+30% +$9.13M 0.26% 116
2016
Q4
$29.6M Sell
375,593
-828,889
-69% -$67.1M 0.23% 131
2016
Q3
$107M Sell
1,204,482
-558,324
-32% -$52.7M 0.79% 19
2016
Q2
$169M Sell
1,762,806
-20,522
-1% -$2.05M 1.28% 6
2016
Q1
$185M Buy
1,783,328
+313,289
+21% +$30.5M 1.48% 4
2015
Q4
$144M Sell
1,470,039
-452,807
-24% -$44.3M 1.23% 8
2015
Q3
$186M Sell
1,922,846
-139,723
-7% -$14.7M 1.41% 6
2015
Q2
$216M Sell
2,062,569
-143,044
-6% -$14.6M 1.64% 3
2015
Q1
$228M Sell
2,205,613
-212,161
-9% -$21.5M 1.71% 3
2014
Q4
$233M Sell
2,417,774
-483,305
-17% -$42.6M 1.67% 5
2014
Q3
$231M Sell
2,901,079
-8,740
-0.3% -$689K 1.65% 7
2014
Q2
$219M Sell
2,909,819
-43,586
-1% -$3.29M 1.57% 7
2014
Q1
$221M Buy
2,953,405
+361,741
+14% +$25.6M 1.7% 7
2013
Q4
$185M Buy
2,591,664
+89,907
+4% +$5.78M 1.54% 9
2013
Q3
$142M Buy
2,501,757
+53,260
+2% +$3.17M 1.38% 11
2013
Q2
$140M Buy
+2,448,497
New +$142M 1.42% 11

Other funds holding CVS

Robeco Institutional Asset Management's CVS Position: Q2 2026 in Review

Robeco Institutional Asset Management reduced its CVS Health (CVS) stake by 15% in Q2 2026, selling an estimated $30.4M and leaving 2,008,760 shares worth $208M. The position accounts for 0.26% of the portfolio, ranked #93.

Robeco Institutional Asset Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $265M in Q4 2025. 547 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Robeco Institutional Asset Management held 2,008,760 shares of CVS Health worth $208M as of Q2 2026.
  • Robeco Institutional Asset Management sold 340,684 CVS Health shares in Q2 2026, an estimated $30.4M.
  • CVS Health made up 0.26% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #93 holding.
  • Robeco Institutional Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Robeco Institutional Asset Management's CVS Health position peaked at $265M in Q4 2025.
  • 547 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.